A limited number of opportunities are available for qualified non-Temple and Temple College of Science and Technology students to participate in a special for-credit research program in Siena, Italy.
Students will be working at the Sbarro Institute for Cancer Research and Molecular Medicine, in collaboration with the Department of Medicine, Surgery and Neurosciences at the University of Siena. The program is overseen by Dr. Antonio Giordano, MD, PhD, Temple University professor and Director of Sbarro Health Research Organization, Dr. Luigi Pirtoli, MD, PHD, professor and director of the Radiation Oncology Unit at the University Hospital of Siena, and faculty and researchers at the University of Siena. Students will begin the program at the IES Abroad Siena Center with a comprehensive orientation, before beginning their six weeks of research. Throughout the program students will participate in cultural field trips, basic Italian language training and guided visits to Italian hospitals or labs.
About the Sbarro Health Research Organization
The Sbarro Health Research Organization is a nonprofit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism.
About the Unit of Radiation Oncology
- Provides a full diagnostic workup and a wide range of therapies of cancer in Italy
- A center of the Tuscany Tumor Institute network system.
- Mainly dedicated to radiotherapy (RT) , or chemotherapy (CHT) integrated with RT, and/ or with biological target therapy.
- Research activities are carried out in Radiation Oncology and Clinical and Experimental Radiation Biology, also in cooperation with the Molecular Pathology Laboratory of the University of Siena.
- The staff is composed of seven senior physicians, seven residents in Radiation Oncology, four medical physicists, one biologist, ten radiographers, and twenty nurses.
- Facilities and resources include : CT -RT simulator, RT treatment planning technology (including MRI –CT image fusion), linear accelerators, providing 3-dimensional conformal RT (3D-CRT), intensity-modulated RT (IMRT), brain and body stereotactic radiotherapy (SRT), radiosurgery (SRS), and image –guided RT (IGRT).
- The unit also has a dedicated ward with 11 beds, sections for Day Hospital and outpatient offices.